• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Brucellosis Market

    ID: MRFR/LS/3722-HCR
    90 Pages
    Kinjoll Dey
    September 2025

    Brucellosis Market research report– by species (Brucella suis, B. abortus, B. melitensis), Diagnosis (serological tests, molecular techniques, bone marrow biopsy, CT, MRI), Treatment (vaccine, antibiotics), End user– Forecast till 2032.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Brucellosis Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Brucellosis Market Summary

    The global brucellosis market is projected to grow significantly from 0.09 USD billion in 2024 to 0.81 USD billion by 2035.

    Key Market Trends & Highlights

    Brucellosis Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 22.62 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 0.81 USD billion, indicating robust growth potential.
    • In 2024, the market is valued at 0.09 USD billion, reflecting the current demand for brucellosis management solutions.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of brucellosis is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.09 (USD Billion)
    2035 Market Size 0.81 (USD Billion)
    CAGR (2025-2035) 22.62%

    Major Players

    Hester Biosciences Limited, ATA FEN Inc., Biogénesis-Bagó S.A., Biopharma, Biovet, Calier & Biologicos Laverlam, Merck Animal Health (MSD Animal Health), Colorado Serum Company, Indian Immunologicals Limited, Dollvet, Veterinary Technologies Corporation, China Animal Husbandry Co., Ltd. (CAHIC), LABIOFAM, BCG Vaccine Laboratory

    Brucellosis Market Drivers

    Rising Incidence of Brucellosis

    The increasing incidence of brucellosis globally is a primary driver for the Global Brucellosis Market Industry. In 2024, the estimated market size is 0.09 USD Billion, reflecting heightened awareness and reporting of the disease. Brucellosis, primarily affecting livestock, poses significant health risks to humans, particularly in regions with high animal husbandry practices. Countries with endemic brucellosis face economic burdens due to livestock losses and healthcare costs. This situation necessitates improved diagnostic and therapeutic solutions, thereby propelling market growth. As awareness spreads, the demand for effective vaccines and treatments is likely to increase, further stimulating the Global Brucellosis Market Industry.

    Government Initiatives and Funding

    Government initiatives aimed at controlling and eradicating brucellosis are pivotal for the Global Brucellosis Market Industry. Various countries are implementing vaccination programs and surveillance systems to monitor and reduce the disease's prevalence. Increased funding for research and development of vaccines and treatments is expected to enhance market growth. For instance, public health campaigns focusing on education and prevention strategies are likely to raise awareness among farmers and the general population. This proactive approach not only aims to reduce infection rates but also encourages investment in the development of innovative solutions, thereby fostering a more robust Global Brucellosis Market Industry.

    Market Trends and Data Visualization

    Growing Awareness of Zoonotic Diseases

    The rising awareness of zoonotic diseases, including brucellosis, is driving the Global Brucellosis Market Industry. Public health organizations are emphasizing the importance of understanding how diseases can transfer from animals to humans. This awareness is particularly relevant in regions where livestock farming is prevalent. As consumers become more informed about the risks associated with zoonotic infections, there is a growing demand for preventive measures, including vaccination and improved food safety practices. This trend is likely to lead to increased investments in research and development, ultimately contributing to the expansion of the Global Brucellosis Market Industry as stakeholders seek to mitigate risks associated with brucellosis.

    Advancements in Diagnostic Technologies

    Technological advancements in diagnostic methods are significantly influencing the Global Brucellosis Market Industry. Enhanced diagnostic tools, such as serological tests and molecular techniques, allow for quicker and more accurate detection of brucellosis. This is crucial for managing outbreaks and implementing control measures effectively. As these technologies become more accessible, healthcare providers are likely to adopt them, leading to an increase in reported cases and subsequent demand for treatment options. The integration of these advanced diagnostics into routine veterinary practices may also contribute to the market's growth, as early detection can mitigate the economic impact of the disease on livestock and public health.

    Projected Market Growth and Economic Potential

    The Global Brucellosis Market Industry is projected to experience substantial growth, with estimates indicating a market size of 0.81 USD Billion by 2035. This growth trajectory, characterized by a compound annual growth rate (CAGR) of 22.62% from 2025 to 2035, suggests a robust demand for brucellosis-related products and services. Factors contributing to this growth include increased investments in vaccine development, enhanced diagnostic capabilities, and rising awareness of the disease's impact on public health. As the market evolves, stakeholders are likely to explore innovative solutions to address the challenges posed by brucellosis, thereby solidifying the industry's position in the global healthcare landscape.

    Market Segment Insights

    Brucellosis Species Insights

    On the basis of species, the brucellosis market is segmented into Brucella suis, Brucella abortus, Brucella melitensis, Brucella canis and others 

    Brucellosis Diagnosis Insights

    On the basis of diagnosis, brucellosis market is segmented into serological tests, molecular techniques, bone marrow biopsy, X-rays, computerized tomography (CT), magnetic resonance imaging (MRI), cerebrospinal fluid culture, echocardiography and others. The serological tests is segmented into serum agglutination test, rose bengal test, lateral flow assay, compliment fixation test, coombs test, enzyme linked immuno sorbent assaym, and immunocapture-agglutination test (brucellacapt). The molecular techniques is segmented into Polymerase Chain Reaction (PCR), Loop- mediated isothermal amplification assay, Multiple Locus VNTR Analysis (MLVA) typing. The Polymerase Chain Reaction (PCR) is further classified into standard PCR, real time PCR, nested PCR, PCR based assays

    Brucellosis Treatment Insights

    On the basis of treatment, brucellosis market is segmented into antibiotics, vaccines, and others

    Brucellosis End-User Insights

    On the basis of end-user, the brucellosis market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.

    Get more detailed insights about Brucellosis Market Research Report - Forecast to 2032

    Key Companies in the Brucellosis Market market include

    Future Outlook

    Brucellosis Market Future Outlook

    The Global Brucellosis Market is projected to grow at a 22.62% CAGR from 2024 to 2035, driven by advancements in diagnostics, increased awareness, and enhanced vaccination programs.

    New opportunities lie in:

    • Develop innovative diagnostic tools for rapid Brucellosis detection in livestock.
    • Expand vaccine distribution networks in emerging markets to enhance accessibility.
    • Invest in research for novel therapeutic agents targeting Brucellosis treatment.

    By 2035, the Brucellosis Market is expected to exhibit robust growth, reflecting increased investment and innovation.

    Report Scope

    Report Scope:
    Attribute/Metric Details
      Market Size   USD 0.63 Billion
      CAGR   8.9%
      Base Year   2021
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Species, Diagnosis, Treatment and End-users
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Hester Biosciences Limited, ATA FEN Inc., Biogénesis-Bagó S.A., Biopharma, Biovet, Calier & Biologicos Laverlam, Merck Animal Health (MSD Animal Health), Colorado Serum Company, Indian Immunologicals Limited, Dollvet, Veterinary Technologies Corporation, China Animal Husbandry Co., Ltd. (CAHIC), LABIOFAM, BCG Vaccine Laboratory, and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Favorable government policies for research·  The presence of a large number of players

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    At what CAGR is the brucellosis market projected to grow in the forecast period (2022-2030)?

    brucellosiss market is projected to grow at approximately 8.9% CAGR during the assessment period (2023-2032).

    What are the major tailwinds pushing the growth of the brucellosis market?

    Favorable government policies for R&D required to discover breakthrough therapeutics and the presence of a large number of players, are major tailwinds pushing the growth of the global brucellosiss market.

    What are the key growth impeders of the brucellosis market?

    The lack of knowledge about the availability of treatments is a major growth impeder for the global brucellosiss market.

    Which region holds the largest share in the brucellosis market?

    Europe holds the largest share in the global brucellosiss market, followed by North America and the Asia Pacific, respectively.

    Who are the top players in the brucellosis market?

    Hester Biosciences Limited, Biogénesis-Bagó S.A., ATA FEN Inc., Biopharma, Merck Animal Health (MSD Animal Health), Biovet, Calier & Biologicos Laverlam, Colorado Serum Company, Dollvet, Indian Immunologicals Limited, Veterinary Technologies Corporation, LABIOFAM, China Animal Husbandry Co., Ltd. (CAHIC), and BCG Vaccine Laboratory, are some of the top players operating in the global brucellosiss market.

    Brucellosis Market Research Report - Forecast to 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials